Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

The switch from buprenorphine to tapentadol: is it worth?

Miclescu A.

Rom J Anaesth Intensive Care. 2016 Oct;23(2):133-139. doi: 10.21454/rjaic.7518/232.bup. Review.

PMID:
28913486
2.

Use of immediate-release opioids as supplemental analgesia during management of moderate-to-severe chronic pain with buprenorphine transdermal system.

Silverman S, Raffa RB, Cataldo MJ, Kwarcinski M, Ripa SR.

J Pain Res. 2017 May 24;10:1255-1263. doi: 10.2147/JPR.S132595. eCollection 2017.

3.

Rifampicin decreases exposure to sublingual buprenorphine in healthy subjects.

Hagelberg NM, Fihlman M, Hemmilä T, Backman JT, Laitila J, Neuvonen PJ, Laine K, Olkkola KT, Saari TI.

Pharmacol Res Perspect. 2016 Nov 3;4(6):e00271. doi: 10.1002/prp2.271. eCollection 2016 Dec.

4.

The New Kid on the Block--Incorporating Buprenorphine into a Medical Toxicology Practice.

Wiegand TJ.

J Med Toxicol. 2016 Mar;12(1):64-70. doi: 10.1007/s13181-015-0518-4. Review.

5.

Effects of buprenorphine on responses to social stimuli in healthy adults.

Bershad AK, Seiden JA, de Wit H.

Psychoneuroendocrinology. 2016 Jan;63:43-9. doi: 10.1016/j.psyneuen.2015.09.011. Epub 2015 Sep 12.

6.

Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome.

Ng CM, Dombrowsky E, Lin H, Erlich ME, Moody DE, Barrett JS, Kraft WK.

Pharmacotherapy. 2015 Jul;35(7):670-80. doi: 10.1002/phar.1610. Epub 2015 Jul 14.

7.

Opioid partial agonist buprenorphine dampens responses to psychosocial stress in humans.

Bershad AK, Jaffe JH, Childs E, de Wit H.

Psychoneuroendocrinology. 2015 Feb;52:281-8. doi: 10.1016/j.psyneuen.2014.12.004. Epub 2014 Dec 9.

8.

Effect of thienorphine on intestinal transit and isolated guinea-pig ileum contraction.

Zhou PL, Li YL, Yan LD, Yong Z, Yu G, Dong HJ, Yan H, Su RB, Gong ZH.

World J Gastroenterol. 2013 Mar 7;19(9):1444-50. doi: 10.3748/wjg.v19.i9.1444.

9.

Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans.

Huestis MA, Cone EJ, Pirnay SO, Umbricht A, Preston KL.

Drug Alcohol Depend. 2013 Aug 1;131(3):258-62. doi: 10.1016/j.drugalcdep.2012.11.014. Epub 2012 Dec 14.

10.

Formulation of buprenorphine for sublingual use in neonates.

Anagnostis EA, Sadaka RE, Sailor LA, Moody DE, Dysart KC, Kraft WK.

J Pediatr Pharmacol Ther. 2011 Oct;16(4):281-4. doi: 10.5863/1551-6776-16.4.281.

11.

Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.

Yokell MA, Zaller ND, Green TC, Rich JD.

Curr Drug Abuse Rev. 2011 Mar;4(1):28-41. Review.

12.

The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers.

Middleton LS, Nuzzo PA, Lofwall MR, Moody DE, Walsh SL.

Addiction. 2011 Aug;106(8):1460-73. doi: 10.1111/j.1360-0443.2011.03424.x. Epub 2011 May 3.

13.

Buprenorphine: a (relatively) new treatment for opioid dependence.

Welsh C, Valadez-Meltzer A.

Psychiatry (Edgmont). 2005 Dec;2(12):29-39.

14.

Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers.

Duke AN, Correia CJ, Walsh SL, Bigelow GE, Strain EC.

Psychopharmacology (Berl). 2010 Aug;211(3):303-12. doi: 10.1007/s00213-010-1898-4. Epub 2010 Jun 25.

15.

Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market.

Bruce RD, Govindasamy S, Sylla L, Kamarulzaman A, Altice FL.

Am J Drug Alcohol Abuse. 2009;35(2):68-72. doi: 10.1080/00952990802585406.

16.

Practical considerations for the clinical use of buprenorphine.

Jones HE.

Sci Pract Perspect. 2004 Aug;2(2):4-20. Review.

17.
18.

Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate.

Avachat A, Kotwal V.

AAPS PharmSciTech. 2007 Oct 19;8(4):E88. doi: 10.1208/pt0804088.

19.

Interpretation of oral fluid tests for drugs of abuse.

Cone EJ, Huestis MA.

Ann N Y Acad Sci. 2007 Mar;1098:51-103. Epub 2007 Mar 1. Review.

20.

Drug testing in oral fluid.

Drummer OH.

Clin Biochem Rev. 2006 Aug;27(3):147-59.

Supplemental Content

Support Center